fda warning bpc-157 unapproved drug peptide safety compounding risks NBC News FDA advisory panel rejects compounding

Many users note that improvements begin within the first week, with substantial healing occurring over 4-8 weeks of consistent use

It is legally dispensed through licensed US compounding pharmacies when prescribed by a medical provider for a specific patient after a clinical evaluation

active ulcer, serious liver disease, hypotension, or gout)

From that point forward, you are relying on two things: the preservative action of the benzyl alcohol and your own impeccable aseptic technique

Peptide Vials (BPC-157 + TB-500, 10 mg blend each) One 10 mg blend vial covers roughly two weeks at the averaged ~700 mcg/day, so plan about one vial every two weeks